AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.33 and traded as high as $6.50. AIkido Pharma shares last traded at $5.69, with a volume of 802,833 shares changing hands.
AIkido Pharma Stock Performance
The company has a market capitalization of $31.18 million, a price-to-earnings ratio of -1.47 and a beta of 0.93. The firm’s 50 day simple moving average is $4.99 and its 200-day simple moving average is $4.33.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- Stock Market Upgrades: What Are They?
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- How to Read Stock Charts for Beginners
- D-Wave Goes International With South Korea Partnership
- What is a Death Cross in Stocks?
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.